Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression The enrollment goal of 125 patients was met. Median age was 46 years (range, 21-65 years), ...
Gary Lyman, MD, MPH, an oncologist and hematologist, compares the uptake of filgrastim biosimlars with pegfilgrastim biosimilars. Gary Lyman, MD, MPH, is an oncologist, hematologist, and public health ...
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. Forty-eight patients with ovarian cancer were treated with cyclophosphamide and randomized to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback